Novavax
NVAX
130 hedge funds and large institutions have $175M invested in Novavax in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 22 closing their positions.
3.53% less ownership
Funds ownership: 53.79% → 50.26% (-3.5%)
9% less funds holding
Funds holding: 143 → 130 (-13)
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
11% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $1.24M
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
39% less capital inflows, than outflows
Capital inflows: $18.9M | Capital outflows: $30.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$4.81M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.43M |
| 3 |
GSA Capital Partners
London,
United Kingdom
|
+$1.68M |
| 4 |
Millennium Management
New York
|
+$1.61M |
| 5 |
JP Morgan Chase
New York
|
+$1.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$9.44M |
| 2 |
Quantitative Investment Management
Charlottesville,
Virginia
|
-$5.15M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.62M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.48M |
| 5 |
Eventide Asset Management
Boston,
Massachusetts
|
-$1.83M |
NVAX Hedge Fund Activity: Q1 2017 in Review
130 of the 4,036 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2017, worth a combined $175M — down 4.8% from $184M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of NVAX and 14 opened new positions — a net loss of 8 holders — while 39 trimmed existing stakes and 35 added.
The largest buyer was D.E. Shaw & Co, adding an estimated $4.81M. The largest seller was State Street, cutting an estimated $9.44M.
- 130 institutional investors held Novavax (NVAX) as of Q1 2017, down from 143 in Q4 2016.
- Funds reported $175M of Novavax stock for Q1 2017, down 4.8% quarter-over-quarter.
- 14 funds opened new Novavax positions in Q1 2017 and 22 closed out, a net change of -8 holders.
- The largest Novavax buyer in Q1 2017 was D.E. Shaw & Co, an estimated $4.81M added.
- The largest Novavax seller in Q1 2017 was State Street, an estimated $9.44M sold.
Based on aggregated 13F filings for Q1 2017.